Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (60)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by COWAN, L. D.
Right arrow Articles by WALLACE, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by COWAN, L. D.
Right arrow Articles by WALLACE, R. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 131, No. 3: 468-482
Copyright © 1990 by The Johns Hopkins University School of Hygiene and Public Health


research-article

CANCER MORTALITY AND LIPID AND LIPOPROTEIN LEVELS

THE LIPID RESEARCH CLINICS PROGRAM MORTALITY FOLLOW-UP STUDY

LINDA D. COWAN1, DIANNE L. O'CONNELL2, MICHAEL H. CRIQUI3, ELIZABETH BARRETT-CONNOR3, TRUDY L. BUSH4 and ROBERT B. WALLACE5

1Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center Oklahoma City, OK
2Centre for Clinical Epidemiology and Biostatistics, Faculty of Medicine, University of Newcastle Newcastle, New South Wales, Australia
3Department of Community and Family Medicine, School of Medicine, University of California at San Diego La Jolla, CA
4Department of Epidemiology, The Johns Hopkins University School of Hygiene and Public Health Baltimore, MD
5Department of Preventive Medicine and Environmental Health, College of Medicine, University of Iowa Iowa City, LA

The associations of serum lipid and lipoprotein levels with the risk of cancer mortality were assessed in 2,753 men and 2,476 women aged 40–79 years at baseline (1972–1976) who participated in the Lipid Research Clinics Program Mortality Follow-up Study through 1984. Seventy-nine cancer deaths occurred in men and 65 occurred in women during an average follow-up time of 8.4years. Total cholesterol and low-density lipoprotein (LDL) cholesterol were significantly inversely associated with overall cancer mortality in men, but no relation was observed in women. Neither high-density lipoprotein (HDL) cholesterol nor tri-gtycerides were significantly related to total cancer mortality in either sex, although in women, HDL cholesterol was positively associated with risk of death from gynecologic cancers. Compared with men with higher cholesterol levels, the relative risk of death from colon cancer, adjusted for age, body mass, cigarette smoking, and alcohol consumption, was 5.20 (95 percent confidence interval (Cl) 1.61–16.8) in men with total cholesterol levels ≤87 mg/dl and 4.79 (95 percent Cl 1.37–16.8) in those with LDL cholesterol levels ≤119 mg/dl. Death from smoking-related cancers was inversely related to baseline total cholesterol but not to LDL cholesterol. The absence of an association with HDL cholesterol, which has been shown to be lower in persons with clinically manifest malignancy, and evidence from survival curves suggest that the inverse relation in men is not due to preexisting disease.

cholesterol; lipids; lipoproteins; lipoproteins, HDL cholesterol; lipoproteins, LDL cholesterol; mortality; neoplasms; triglycerides


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
X. Yang, W.-Y. So, R. C W Ma, G. T C Ko, A. P S Kong, Q. Wang, C. S Cockram, C.-C. Chow, J. C N Chan, and P. C Y Tong
Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes
Endocr. Relat. Cancer, June 1, 2008; 15(2): 597 - 607.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. H. Eliassen, G. A. Colditz, B. Rosner, W. C. Willett, and S. E. Hankinson
Serum Lipids, Lipid-Lowering Drugs, and the Risk of Breast Cancer
Arch Intern Med, October 24, 2005; 165(19): 2264 - 2271.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Cullen, H. Schulte, and G. Assmann
The Munster Heart Study (PROCAM) : Total Mortality in Middle-Aged Men Is Increased at Low Total and LDL Cholesterol Concentrations in Smokers but Not in Nonsmokers
Circulation, October 7, 1997; 96(7): 2128 - 2136.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Fagot-Campagna, R. L. Hanson, K. M. V. Narayan, M. L. Sievers, D. J. Pettitt, R. G. Nelson, and W. C. Knowler
Serum Cholesterol and Mortality Rates in a Native American Population With Low Cholesterol Concentrations : A U-Shaped Association
Circulation, September 2, 1997; 96(5): 1408 - 1415.
[Abstract] [Full Text]


Home page
CirculationHome page
C. Iribarren, D. M. Reed, R. Chen, K. Yano, and J. H. Dwyer
Low Serum Cholesterol and Mortality : Which Is the Cause and Which Is the Effect?
Circulation, November 1, 1995; 92(9): 2396 - 2403.
[Abstract] [Full Text]


Home page
BMJHome page
G. Wannamethee, A G. Shaper, P. H Whincup, and M. Walker
Low serum total cholesterol concentrations and mortality in middle aged British men
BMJ, August 12, 1995; 311(7002): 409 - 413.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.